Skip to content

MAM01026 and MAM00348 have the same name, an issue for VMH #375

Closed

Description

@ANiknejad

hello,

Could you please have a look at the '2 metabolites found' here:
https://www.vmh.life/#allsearch/oretn

MAM01026 4-oxo-13-cis-retinoate is 'oretn'
MAM00348 13-cis-oxo-retinoate is '13_cis_oretn'

the name is similar/identical but only MAM00348 corresponds to the -cis stereo form at carbon 13 (I recently created the corresponding chebi for that chemical, should hopefully be validated soon as CHEBI:190136)
MAM01026 is the compound that can be mapped to CHEBI:134186 all-trans-4-oxoretinoate, both have the same mol file actually

As a consequence, I send this message to VMH via their contact form, and I hope you agree

Hello Team,

I am currently doing chemical curation work for MetaNetX.org.
It sounds like the compounds with abbreviation '13_cis_oretn' and 'oretn' have the same name (13-Cis-Oxo-Retinoic Acid, and 4-Oxo-13-Cis-Retinoate), while only '13_cis_oretn' corresponds to the structure with a -cis stereo at carbone 13. 'oretn' should maybe be redefined as 'all-trans-4-oxoretinoate' such as CHEBI:134186, right?

Thank you in advance and best regards,

Anne

Anne Niknejad
Senior biocurator
SIB | Swiss Institute of Bioinformatics Unil, Department of Ecology and Evolution - Quartier Sorge, bâtiment Biophore - 1015 Lausanne t: +41 21 692 42 21 - f: +41 21 692 41 65 Anne.Niknejad@sib.swiss - https://www.sib.swiss

I hereby confirm that I have:

  • Tested my code on my own computer for running the model
  • Done this analysis in the main branch of the repository
  • Checked that a similar issue does not exist already

Activity

  1. JonathanRob commented on Mar 28, 2022

    @JonathanRob
    Collaborator

    Thanks @ANiknejad for identifying this. It seems that both metabolites (MAM01026 and MAM00348) are supposed to correspond to the same 4-oxo-13-cis form, though some of the reactions in which they are involved in Human-GEM may need to be investigated (e.g. MAR08703). The all-trans-4-oxo form is actually already present in the model as the MAM01031 metabolite.

    Therefore, to address this issue, I suspect that we will need to do the following:

    1. Merge the MAM01026 and MAM00348 metabolites (remove one from the model).
    2. Evaluate the reactions in which these metabolites are involved to determine if instead the all-trans metabolite MAM01031 should be used instead.
    3. Update cross references (i.e. ChEBI IDs) of these metabolites accordingly.
  2. self-assigned this
    on Mar 28, 2022
  3. edkerk commented on Jul 11, 2026

    @edkerk
    Member

    Thanks for the careful report. Digging in, this turned out to be the reverse of what the naming suggests, so I did an adversarial check against the databases and the reactions before changing anything.

    Both metabolites are the same compound, and it is 4-hydroxy, not 4-oxo. MAM01026 was conflated: it carried two MetaNetX IDs pointing at different stereoisomers (MNXM37697 = 13-cis, MNXM6902 = all-trans, CHEBI:134186), which is exactly why its structure looked all-trans while the model used it as cis. But the deeper issue is the oxidation state:

    • MAM01026/MAM00348 have formula C20H27O3, which is 4-hydroxyretinoate (anion), matching the real 4-hydroxy-all-trans-retinoate (MAM00993) and 4-hydroxy-13-cis-retinoic acid. The true 4-oxo forms (all-trans MAM01031, 9-cis MAM01029) are C20H25O3.
    • Every reaction that makes them (MAR06681/06682/08703/08706) is a hydroxylation that adds one O and removes no H.

    So the formula and reactions are consistent with 4-hydroxy; only the name and cross-refs said 4-oxo. Changing the formula to true 4-oxo would have unbalanced all four reactions, so the fix is to correct the name.

    What was done:

    Change Detail
    Merge MAM00348 merged into MAM01026 (identical compound)
    Rename MAM01026 -> "4-hydroxy-13-cis-retinoate" (formula C20H27O3 kept)
    Cross-refs removed the incorrect 4-oxo MetaNetX IDs (MNXM37697, MNXM6902, MNXM146866)
    MAR08703 fixed so all-trans-retinoate gives the all-trans product (MAM00993), not the 13-cis form
    Removed MAR08704 (interconversion of the two duplicates) and MAR01564 (duplicate nuclear transport of MAR01563)

    All modified reactions remain mass and charge balanced. One thing to note: the true 4-oxo-13-cis-retinoate (the major isotretinoin metabolite) is now not represented in the model; adding it along with the 4-hydroxy -> 4-oxo step, mirroring the all-trans pathway (MAR06702/06703), would be a sensible follow-up.

  4. added
    wipA pull request for this issue is open
    on Sep 24, 2026
  5. edkerk commented on Sep 28, 2026

    @edkerk
    Member

    Follow-up to #1044, in #1105 (open): The retinoate 4-hydroxylation and 4-oxo GPRs now follow single-isoform human data (CYP2C9, CYP2B6, CYP2C19, CYP3A5 and CYP26A1 added where shown; CYP1B1 and CYP4A11 left out), and CYP26C1 (new gene, UniProt Q6V0L0) is added to the all-trans and 9-cis 4-hydroxylations and 4-oxo steps (RHEA:51984, 75851, 75847, 75855; PMID:14532297) and the 13-cis 4-hydroxylation (PMID:29476041). Rhea ids are added, the lumped MetaNetX ids are removed from the split hydroxylations, and 4-hydroxy-9-cis-retinoate (MAM20091) gets CHEBI:139253, MNXM1107686 and LMPR01090053. Details and evidence are in the comment on #1044.

  6. removed
    wipA pull request for this issue is open
    on Sep 28, 2026
  7. added this to the 2.1.0 milestone on Sep 28, 2026
  8. edkerk commented on Oct 5, 2026

    @edkerk
    Member

    Fixed in Human 2.1.0.

  9. removed
    fixed in developMerged into develop, will be in the next release
    on Oct 14, 2026
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment

Metadata

Metadata

Assignees

Labels

No labels
No labels

Type

No type

Projects

No projects

    Milestone

    Relationships

    None yet

    Development

    No branches or pull requests

    Issue actions